Advanced Filters
noise
Found 65,199 clinical trials
L Li Tian

Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.

The goal of this observational study is to use endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) to investigate the intratumoral microbiome profile in patients with pancreatic ductal adenocarcinoma (PDAC) and to evaluate its potential impact on tumor diagnosis and prognosis. PDAC is the most common and lethal type of pancreatic cancer, accounting …

18 - 80 years of age All Phase N/A
V Valerie Dahm, MD

Intraoperative EABR for Decision Making

In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation are included. The goal of the study is to correlate the eABR results with postoperative hearing results.

18 - 99 years of age All Phase N/A

A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR

The main purpose is to evaluate the accuracy of myocardial imaging obtained through integrated 18F-FDG PET/MR in detecting viable myocardium. The secondary objective is to evaluate whether myocardial imaging obtained through integrated 18F-FDG PET/MR can replace 18F-FDG PET combined with 99mTc MIBI SPECT/CT gated myocardial perfusion imaging.

- 80 years of age All Phase N/A
Z Zhe Zheng, MD, PhD

Consistency of LGE-MRI Fibrosis and EAM Low-voltage Area

This study aims to: Assess the consistency of LGE-MRI bi-atrial fibrosis and electroanatomical mapping of bi-atrial low voltage region To evaluate the electroanatomical characteristics of different types of fibrosis (dense fibrosis, patchy fibrosis, etc.) in different locations of the left and right atrium; To explore the correlation between preoperative and …

18 years of age All Phase N/A
M Marion FERREIRA, Dr

Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study

Lung cancer is the leading cause of cancer-related death in France and globally, with 2.48 million new cases diagnosed in 2022, accounting for nearly 13% of global cancer incidence. Despite recent advances, it remains a major health issue due to late-stage diagnosis and high patient and societal burden. New insights …

18 years of age All Phase N/A
N Naciye Vardar-Yağlı, Prof. Dr.

Exercise Capacity in Kidney Transplant Recipients

This study aimed to determine the determinants of 6 minute walk test distance in patients with kidney transplant recipients.

18 - 65 years of age All Phase N/A
M Mehmet K ALTUNOK, PHD(c) in PT

Validity and Reliability of the 6-minute Pegboard Ring Test in Obese Individuals

Obesity is a major public health problem that causes numerous diseases and problems that threaten human health. The prevalence of obesity has increased worldwide in the last ~50 years and has reached pandemic levels. Similar results are seen in Turkey, and according to the results of the Turkey Health Survey, …

18 years of age All Phase N/A

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

This project will evaluate the efficacy and safety of the conditioning regimen bortezomib-bendamustine-melphalan (BBM) in combination with autologous hematopoietic stem cell transplantation (ASCT) in relapsed multiple myeloma given from 2011 to 2018 at Uppsala University Hospital. This approach will be retrospectively compared to high dose melphalan (HDM) in the same …

18 years of age All Phase N/A
L Lian Yang

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach(Radiogenomics-Urinary)

This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.

18 years of age All Phase N/A
L Luigi Buonaguro

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: From Benchside to Bedside (HepAnt) - Study of the Role of the Metagenome in Head and Neck Tumors Using Omics Techniques (HeNomics).

18 - 100 years of age All Phase N/A

Simplify language using AI